Transmedics Group Stock Buy Hold or Sell Recommendation
| TMDX Stock | USD 68.53 4.18 6.50% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding TransMedics Group is 'Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell TransMedics Group given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for TransMedics Group, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out TransMedics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as TransMedics and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards TransMedics Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
TransMedics |
Execute TransMedics Buy or Sell Advice
The TransMedics recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on TransMedics Group. Macroaxis does not own or have any residual interests in TransMedics Group or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute TransMedics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Insignificant | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
TransMedics Trading Alerts and Improvement Suggestions
| TransMedics Group had very high historical volatility over the last 90 days | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from globenewswire.com: ROSEN, THE FIRST FILING FIRM, Encourages TransMedics Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm TMDX |
TransMedics Returns Distribution Density
The distribution of TransMedics' historical returns is an attempt to chart the uncertainty of TransMedics' future price movements. The chart of the probability distribution of TransMedics daily returns describes the distribution of returns around its average expected value. We use TransMedics Group price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of TransMedics returns is essential to provide solid investment advice for TransMedics.
| Mean Return | 0.09 | Value At Risk | -6.92 | Potential Upside | 7.19 | Standard Deviation | 4.20 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of TransMedics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
TransMedics Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as TransMedics, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading TransMedics Group back and forth among themselves.
| Shares | Amvescap Plc. | 2024-12-31 | 678.6 K | Eventide Asset Management, Llc | 2024-12-31 | 677.7 K | Liontrust Investment Partners Llp | 2024-12-31 | 596.4 K | Ubs Group Ag | 2024-12-31 | 590.2 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 454.4 K | Wasatch Advisors Lp | 2024-12-31 | 441.4 K | Goldman Sachs Group Inc | 2024-12-31 | 420.8 K | Man Group Plc | 2024-12-31 | 395.4 K | Emerald Advisers, Llc | 2024-12-31 | 371.7 K | Blackrock Inc | 2024-12-31 | 5.2 M | Fmr Inc | 2024-12-31 | 4 M |
TransMedics Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (1.7M) | (4.9M) | (8.0M) | (28.1M) | (8.4M) | (8.8M) | |
| Investments | (41.1M) | 32.8M | 54.5M | (154.9M) | (129.3M) | (122.8M) | |
| Change In Cash | 4.5M | 999K | 175.6M | 193.6M | (58.2M) | (55.3M) | |
| Depreciation | 1.6M | 1.8M | 3.5M | 8.2M | 19.8M | 20.7M | |
| Capital Expenditures | 455K | 3.5M | 11.9M | 179.1M | 129.7M | 136.2M | |
| Net Income | (28.7M) | (44.2M) | (36.2M) | (25.0M) | 35.5M | 37.2M | |
| End Period Cash Flow | 25.1M | 26.1M | 201.7M | 395.3M | 337.2M | 354.0M | |
| Change To Netincome | 1.7M | 2.5M | 7.8M | 13.7M | 15.7M | 16.5M | |
| Free Cash Flow | (30.7M) | (32.4M) | (57.7M) | (192.1M) | 48.8M | 51.2M | |
| Other Non Cash Items | 511K | 1.4M | 3.4M | 30.0M | 48.8M | 51.2M |
TransMedics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to TransMedics or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that TransMedics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a TransMedics stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.21 | |
β | Beta against Dow Jones | 1.20 | |
σ | Overall volatility | 4.32 | |
Ir | Information ratio | 0.05 |
TransMedics Volatility Alert
TransMedics Group shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure TransMedics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact TransMedics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.TransMedics Fundamentals Vs Peers
Comparing TransMedics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze TransMedics' direct or indirect competition across all of the common fundamentals between TransMedics and the related equities. This way, we can detect undervalued stocks with similar characteristics as TransMedics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of TransMedics' fundamental indicators could also be used in its relative valuation, which is a method of valuing TransMedics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare TransMedics to competition |
| Fundamentals | TransMedics | Peer Average |
| Return On Equity | 0.19 | -0.31 |
| Return On Asset | 0.031 | -0.14 |
| Profit Margin | 0.08 % | (1.27) % |
| Operating Margin | 0.07 % | (5.51) % |
| Current Valuation | 2.35 B | 16.62 B |
| Shares Outstanding | 33.66 M | 571.82 M |
| Shares Owned By Insiders | 3.49 % | 10.09 % |
| Shares Owned By Institutions | 96.51 % | 39.21 % |
| Number Of Shares Shorted | 10.76 M | 4.71 M |
| Price To Book | 9.48 X | 9.51 X |
| Price To Sales | 5.22 X | 11.42 X |
| Revenue | 441.54 M | 9.43 B |
| Gross Profit | 262.08 M | 27.38 B |
| EBITDA | 69.95 M | 3.9 B |
| Net Income | 35.46 M | 570.98 M |
| Cash And Equivalents | 204.46 M | 2.7 B |
| Cash Per Share | 6.41 X | 5.01 X |
| Total Debt | 458.92 M | 5.32 B |
| Debt To Equity | 0.36 % | 48.70 % |
| Current Ratio | 12.11 X | 2.16 X |
| Book Value Per Share | 6.80 X | 1.93 K |
| Cash Flow From Operations | 48.8 M | 971.22 M |
| Short Ratio | 6.26 X | 4.00 X |
| Earnings Per Share | 1.07 X | 3.12 X |
| Target Price | 102.86 | |
| Number Of Employees | 728 | 18.84 K |
| Beta | 2.12 | -0.15 |
| Market Capitalization | 2.31 B | 19.03 B |
| Total Asset | 804.08 M | 29.47 B |
| Retained Earnings | (468.24 M) | 9.33 B |
| Working Capital | 437.3 M | 1.48 B |
| Net Asset | 804.08 M |
Note: Disposition of 300 shares by Hassanein Waleed H of TransMedics at 135.04 subject to Rule 16b-3 [view details]
TransMedics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as TransMedics . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About TransMedics Buy or Sell Advice
When is the right time to buy or sell TransMedics Group? Buying financial instruments such as TransMedics Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having TransMedics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Management Thematic Idea Now
Management
Companies providing management services to businesses. The Management theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Management Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for TransMedics Stock Analysis
When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.